By Ben Glickman Great Ajax Corp. said it wouldn’t be acquired by Ellington Financial after the two real-estate investment trusts agreed to…
Don’t miss these top money and investing features: Sign up here to get MarketWatch’s best mutual funds and ETF stories emailed to you…
Europe’s carmakers face bottom-line damaging penalties as early as next year as rules to outlaw new internal combustion engines (ICE) begin to…
Imagine you knew that 80% of the homes in your neighborhood would eventually suffer damage in a storm—but less than 4% of…
Nike and Lululemon Aren’t the Only Names in Athleisure. More Stocks to Play the Trend.
By Press Room
5 Mins read
There’s a three-block stretch of Fifth Avenue near Barron’s Manhattan offices that you could call Lycra Way. Within a three-minute walk, shoppers…
While Citizens Financial Group operates 1,110 branches in 14 states, mostly in the eastern half of the U.S., it has now launched…
Opinion: Biotech stocks are in a post-pandemic slump and recovery in 2024 is questionable
By Press Room
3 Mins read
Novavax NVAX, +5.24% stands out as a stark reminder of the biotech sector’s faltering steps in 2023. Once renowned for its Nuvaxovid…
The stock market, as measured by the S&P 500 Index SPX, is struggling to maintain some bullishness after bouncing off support at…
Middlemen pocket 70% of Medicare spending on widely used generic drugs, study finds
By Press Room
3 Mins read
About 70 cents of every dollar spent on widely used generic drugs under Medicare’s Part D prescription-drug benefit goes into the pockets…
Hulu has a loaded lineup in November 2023, with a pair of highly anticipated FX dramas, an epic Baz Luhrmann miniseries and…